Aptorum Group, DiamiR announce New York state approval for APOE Genotyping test

DiamiR Biosciences and Aptorum Group (APM) announced that DiamiR received a Clinical Laboratory Evaluation Program, CLEP, Test Approval for its APOE Genotyping test from the New York State Department of Health, NYSDOH. This milestone allows DiamiR to offer its validated APOE Genotyping molecular testing in a variety of biological samples, such as blood, buccal swab, saliva, and tissue, through its Clinical Laboratory Improvement Amendments certified, College of American Pathologists accredited clinical laboratory by licensed healthcare providers in New York State and nationwide.